Business context and reporting period
Park City Group, Inc. (Nasdaq: PCYG), the parent of ReposiTrak, Inc., filed this Form 10-Q for the three months ended September 30, 2021—its fiscal 2022 first quarter. The company provides SaaS supply-chain, compliance, food-safety and B2B marketplace services, primarily to food retailers, wholesalers and suppliers. The filing reports consolidated results, not standalone ReposiTrak financials.
Financial performance and position
| Metric | Three months ended Sep. 30, 2021 | Prior-year quarter | Change |
|---|---|---|---|
| Revenue | $4.56 million | $5.23 million | Down 13% |
| Operating income | $1.17 million | $0.63 million | Up 85% |
| Net income | $0.95 million | $0.55 million | Up 71% |
| Net income applicable to common stockholders | $0.80 million | $0.41 million | Up 96% |
| Basic and diluted EPS | $0.04 | $0.02 | Higher |
| Operating cash flow | $1.12 million | $1.22 million | Down 9% |
Recurring subscription, support and services revenue rose 10% to $4.41 million. Non-recurring services revenue fell 62% to $51,000, while transaction-based Marketplace revenue fell 91% to $103,000. Cost of revenue and product support declined 57% to $846,000. Derived gross margin was approximately 81% versus 62%; operating margin was approximately 26% versus 12%.
At September 30, cash was $20.43 million, total assets $49.67 million, and stockholders’ equity $46.13 million. Working capital was $23.14 million. The company had no line-of-credit balance at quarter-end after repaying $6.0 million; it reported $674,000 of operating lease liabilities. The quarter’s $3.64 million cash decline reflected the credit-line repayment, partly offset by $1.12 million of operating cash flow and $1.37 million from asset sales.
Material changes, outlook and risks
- Revenue declined because elevated Marketplace sales during the prior-year COVID-19 disruption—particularly sales of personal protective equipment and other hard-to-find products—did not recur. Management said future PPE demand and Marketplace revenue could fluctuate.
- Management is emphasizing recurring subscription revenue over transactional sales. It reported that the ReposiTrak Traceability Network launched in September 2021, with phased rollouts and expected scaling in the latter half of fiscal 2022; adoption and timing remain uncertain.
- On October 6, 2021, the company entered a new $10 million revolving credit facility, effective September 30, 2021, replacing the prior $6 million facility. It matures March 31, 2023, bears interest at 1.75% plus one-month LIBOR, and includes covenants, including a minimum liquid-assets requirement tied to the outstanding note and a maximum senior funded debt-to-EBITDA ratio of 3:1.
- Management believes cash, short-term investments and operating cash flows are sufficient for at least 12 months, and expects cash flow and working capital to improve, but provides no quantitative earnings or revenue guidance. COVID-19 had not materially harmed the reported quarter, but future effects are uncertain.
- Other notable items include $149,000 of unrealized losses on short-term investments, an $83,000 other loss, and a $108,000 loss on sale of property and equipment. Preferred dividends were $146,611 for the quarter; Series B and B-1 preferred shares carry stated annual dividend rates of 7% if paid in cash or 9% if paid in additional shares.
- The company reported no new risk factors, no pending or threatened material legal proceedings, and no material changes to internal control over financial reporting. It identifies interest-rate exposure on short-term investments and relies on estimates for areas including revenue recognition and goodwill valuation.
Important facts for investors to verify
- Whether recurring subscription growth can offset the sharp decline and potential volatility in Marketplace transaction revenue.
- Progress and commercial adoption of the Traceability Network and newer quality-management products.
- Availability under the new credit facility and ongoing compliance with its liquidity and leverage covenants.
- The cash cost and terms of preferred dividends, and the potential effects of outstanding preferred shares, warrants and stock-based compensation.
- Whether management’s expected improvement in operating cash flow and working capital materializes.